unknown
Stage
2
Investors
About
Endogenex develops a novel pulsed electric field (PEF) device, the pulsENDO system, which is designed to reset the metabolic signaling in the small intestine to improve blood glucose control for people living with type 2 diabetes. The system is currently investigational and evaluated in clinical studies.
Explore Endogenex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.